UltraSight: Quality Cardiac Sonography for any Practice

article image

Cardiovascular disease is as prevalent as ever, yet cardiologists and advanced imaging resources remain relegated to major hospitals. UltraSight combines proprietary AI with vetted clinical expertise to enhance the average clinician's ability to render quality images from handheld probes and interpret them with accuracy, bringing access to high-level care to a greater population than ever before.

In 2018, UltraSight Ltd. (originally OnSight Medical) was forged as a joint venture between deep technology AI experts at the Weizmann Institute of Science and experienced clinicians at the NYU Langone Medical Center with the objective to yield informative cardiac sonography from a handheld ultrasound probe regardless of operator skill level.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: